Docusate Sodium And Sennosides Tablet
Product Images NDC 62993-0002

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Docusate Sodium And Sennosides (NDC 62993-0002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Morepen Laboratories Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100 Tablets Principle Display Panel (100 Pdp)

Label for Docusate Sodium 50 mg and Sennosides 8.6 mg Tablets by Morepen Laboratories Limited, showing the product name, active ingredient strengths, and package count of 100 tablets. The label indicates it is a dual-action, gentle constipation relief tablet.*

FDA Label Image

1000 Tablets Principle Display Panel (1000 Pdp)

Drug Facts label for Docusate Sodium 50 mg & Sennosides 8.6 mg Tablets by Dr. Morepen includes active ingredients and their purposes, uses, warnings, dosage directions by age group, other ingredient details, inactive ingredients, storage instructions, and contact information for questions. Packaging mentions 1000 tablets per container.*

FDA Label Image

30 Tablets Principle Display Panel (30 Pdp)

Packaging label for Docusate Sodium 50 mg and Sennosides 8.6 mg tablets by Morepen Laboratories Limited. The label shows the product name with active ingredients and strengths, indicates it contains 30 tablets, and includes distribution information, warnings, directions, drug facts, and a barcode. The tablets are for oral use. The label emphasizes constipation relief and dual action with standardized Senna concentrate.*

FDA Label Image

3000 Tablets Principle Display Panel (3000 Pdp)

Packaging label for Docusate Sodium 50 mg & Sennosides 8.6 mg Tablets by Morepen Laboratories Limited. The label shows the product name, active ingredients with strengths, and indicates 3000 tablets in the package. It also includes Drug Facts with active ingredients, usage, warnings, directions by age group, and inactive ingredients. Distributed by Morepen Bio Inc.*

FDA Label Image

60 Tablets Principle Display Panel (60 Pdp)

Label for Docusate Sodium 50 mg and Sennosides 8.6 mg tablets by Morepen Laboratories Limited. The label shows the active ingredients and strengths, package quantity of 60 tablets, distributor details, and a barcode. It also highlights the product's use for constipation relief and includes warnings, directions, and inactive ingredients.*

FDA Label Image

Active Ingredient Label (Active Ingredients)

A Drug Facts panel listing active ingredients and their purposes for Docusate Sodium and Sennosides tablets. It states Docusate sodium USP 50 mg as a stool softener and Sennosides 8.6 mg as a laxative.*

FDA Label Image

Dosage & Administration (Dosage And Administration)

This image shows dosing directions for Docusate Sodium and Sennosides tablets. It provides starting and maximum dosages based on age groups: adults and children 12 years and over, children 6 to under 12 years, children 2 to under 6 years, and children under 2 years, for whom a doctor should be consulted. It advises taking the medication preferably at bedtime or as directed by a doctor.*

FDA Label Image

Inactive Ingredients Label (Inactive Ingredients)

A drug facts panel listing the inactive ingredients of a Docusate Sodium and Sennosides tablet. Inactive ingredients include colloidal silicon dioxide, croscarmellose sodium, dibasic calcium phosphate, FD&C Yellow #5 Lake, FD&C Yellow #6 Lake, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, povidone, talc, and titanium dioxide. It notes that FD&C Yellow #5 Lake (tartrazine) is used as a color additive.*

FDA Label Image

Indications & Usage (Indications And Usage)

Drug Facts panel titled 'Uses' lists that the product relieves occasional constipation (irregularity) and generally produces a bowel movement in 6-12 hours. The text is black on a white background within a black border.*

FDA Label Image

Keep Out Of Reach Of Children (Keep Out Of Reach Of Children)

A boxed warning panel stating: "Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away." The text emphasizes safety precautions related to overdose.*

FDA Label Image

Storage And Handling (Other Information)

This image shows an "Other information" panel from the Docusate Sodium and Sennosides tablet label. It states each tablet contains calcium 17.7 mg and sodium 4.4 mg with very low sodium. It also includes storage instructions to keep at 25°C (77°F) with permitted excursions between 15-30°C (59-86°F).*

FDA Label Image

Purpose Label (Purpose)

Drug Facts panel showing active ingredients per tablet for Docusate Sodium and Sennosides. It lists Docusate Sodium USP 50 mg as a stool softener and Sennosides 8.6 mg as a laxative.*

FDA Label Image

Questions Section Label (Questions)

A customer service contact information panel instructing to call a toll-free number for questions or comments, with hours Monday to Friday 9AM to 5PM EST. It also provides an FDA contact number and a website URL for FDA MedWatch reporting.*

FDA Label Image

Warnings (Warning Docusate)

This image shows a warnings panel for Docusate Sodium and Sennosides oral tablets. It includes precautions about mineral oil, laxative use duration, symptoms requiring a doctor's consultation, stopping use instructions, and advice for pregnant or breastfeeding individuals. It also warns to keep the product out of children's reach and to seek immediate medical help in case of overdose.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.